Clinical Coding & Superbill Tool

ME/CFS & Dysautonomia ICD-10 Medical Billing Guide: G93.32, G90.A & Superbill Generator

Author: Healthcare Reimbursement & Advocacy Panel Reviewed: October 2026 Evidence Level: CDC / WHO ICD-10-CM Official Coding Guidelines Reading Time: 11 min

1. The 2022 CDC Coding Breakthrough: G93.32 & G90.A

For decades, insurance claims for ME/CFS and dysautonomia were routinely denied because physicians submitted non-specific symptom codes such as R53.82 (Chronic fatigue, unspecified) or R42 (Dizziness and giddiness). Insurance claims examiners and disability reviewers weaponized these generic codes to classify patients as "merely tired" or "depressed."

On October 1, 2022, the Centers for Disease Control and Prevention (CDC) formally established specific, dedicated diagnosis codes in the ICD-10-CM:

  • G93.32 – Myalgic encephalomyelitis/chronic fatigue syndrome: Explicitly classifies ME/CFS as a distinct neurological and immunological disease entity under Chapter 6 (Diseases of the nervous system).
  • G90.A – Postural orthostatic tachycardia syndrome (POTS): The first official specific code for POTS, ending years of ambiguity under generic autonomic codes.
Superbill Generator

Interactive ME/CFS & Dysautonomia Superbill Builder

Instant Insurance Note

Select your primary and secondary clinical diagnoses to compile an official medical necessity sheet for insurance pre-authorizations, superbill out-of-network claims, and disability documentation.

Official ICD-10 Clinical Coding Dossier



          

            
              Disability Appeals & RFC Form Guide →
            
            
          

          
        

      


      

        
2. Master ICD-10-CM Coding Table for Complex Chronic Illness

        

          

            
              

                ICD-10 Code
                Official Clinical Description
                When to Use & Reimbursement Impact
              

            
            
              

                G93.32
                Myalgic encephalomyelitis/chronic fatigue syndrome
                Primary Code: Required for all ME/CFS clinical claims. Qualifies for complex evaluation (CPT 99215).
              

              

                G90.A
                Postural orthostatic tachycardia syndrome (POTS)
                Diagnostic: Supports tilt table testing (CPT 95921/95922), IV saline therapy, and autonomic drugs.
              

              

                U09.9
                Post COVID-19 condition, unspecified
                Used when symptom onset directly followed confirmed or suspected SARS-CoV-2 infection.
              

              

                G47.8
                Other sleep disorders (Alpha-delta sleep intrusion)
                Justifies overnight polysomnography (PSG) and non-benzodiazepine hypnotics.
              

              

                D89.40
                Mast cell activation, unspecified
                Supports prescription mast cell stabilizers (Cromolyn sodium, Ketotifen) and DAO enzymes.
              

              

                G60.8
                Other specified hereditary and idiopathic peripheral neuropathies
                Used for biopsy-proven Small Fiber Neuropathy (SFN) and autonomic denervation.
              

              

                R53.82 (Avoid)
                Chronic fatigue, unspecified
                High Denial Risk: Generic symptom code frequently rejected by disability insurers. Always upgrade to G93.32.
              

            
          

        

      


      

        
Related Healthcare Navigation Guides